EQT Fund Management S.a r.l.
LUXEMBOURG, N4
$863m in 5 US stocks at the end of 30 June 2026. The top 10 are 100.0% of the money. It changed about 7.2% of the portfolio this quarter.
Value
$863m
Stocks
5
Top 10 share
100.0%
Turnover
7.2%
What changed this quarter
New
Bought for the first time this quarter.
None this quarter.
Added
Bought more of a stock they already held.
- Oculis Holding AGOCS11.2% of the fund+18%
- EvommuneEVMN8.1% of the fund+7%
Cut
Sold some of their stake.
None this quarter.
Sold out
Sold their entire stake.
None this quarter.
Holdings
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| Waystar HoldingWAY | 59.2% | $511m | 24,879,437 | Held |
| PharvarisPHVS | 13.7% | $118m | 3,424,609 | Held |
| Oculis Holding AGOCS | 11.2% | $96m | 6,950,294 | +18% |
| EvommuneEVMN | 8.1% | $70m | 5,288,313 | +7% |
| AgomAb Therapeutics NVAGMB | 7.7% | $67m | 5,141,992 | Held |
Over time and by industry
Value over time
Dec '25
Jun '26
Value is down 53.7% since 30 September 2025.
Where the money is
Technology59.2%
Health care40.8%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.